Barinthus Biotherapeutics
BRNS
#9387
Rank
A$60.37 M
Marketcap
$1.50
Share price
-29.70%
Change (1 day)
-66.07%
Change (1 year)

Revenue for Barinthus Biotherapeutics (BRNS)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of A$1.17 Million a decrease over the revenue in the year 2022 that were of A$65.69 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Barinthus Biotherapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A-100%
2023 A$1.17 M-98.21%
2022 A$65.69 M17670.42%
2021 A$0.36 M-94.1%
2020 A$6.26 M